Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

News

  1. Home>
  2. News>
  3. News>
  4. Page 15

CDSCO Tightens Drug Quality: Outsourced Audits, 1,500 Experts, Tighter Safety Rules

  • Post published:June 11, 2026
  • Post category:News

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is implementing one of the most ambitious regulatory overhauls in its history. In a series of coordinated actions between February…

Continue Reading CDSCO Tightens Drug Quality: Outsourced Audits, 1,500 Experts, Tighter Safety Rules

India Pharma 2026 Highlights 7.7% Growth and Global Pharma Push

  • Post published:June 9, 2026
  • Post category:News

The 9th edition of India Pharma 2026, the flagship event of the Department of Pharmaceuticals under India's Ministry of Chemicals and Fertilizers, has spotlighted India's growing influence in the global…

Continue Reading India Pharma 2026 Highlights 7.7% Growth and Global Pharma Push

India’s Semaglutide Generic Boom Reshapes GLP-1 Market in 2026

  • Post published:June 5, 2026
  • Post category:News

On March 20, 2026, Novo Nordisk's patent on semaglutide expired in India, triggering one of the most significant transformations in the country's pharmaceutical history. Within weeks, more than 40 Indian…

Continue Reading India’s Semaglutide Generic Boom Reshapes GLP-1 Market in 2026

CDSCO 2026 Overhaul: GMP Audits Outsourced, 1,500 Experts Hired as India Tightens Pharma Quality Standards

  • Post published:June 3, 2026
  • Post category:News

The Central Drugs Standard Control Organization (CDSCO) is undertaking its most significant regulatory transformation in decades. In a series of reforms announced in early 2026, India's drug regulator has unveiled…

Continue Reading CDSCO 2026 Overhaul: GMP Audits Outsourced, 1,500 Experts Hired as India Tightens Pharma Quality Standards
  • Go to the previous page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 20
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve